Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Psychotherapy01:28

Psychotherapy

Psychotherapy is a versatile, nonmedical approach aimed at helping individuals address emotional, behavioral, and interpersonal issues to enhance their overall well-being. It can involve one-on-one sessions, couples counseling, or small group discussions with a therapist. The therapeutic process includes various techniques such as open discussion, interpretation of thoughts and behaviors, active listening, positive reinforcement, and role modeling. Psychotherapy aims to support individuals in...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: New approaches for improving equity in mental health research, treatment, and policy.

Frontiers in psychiatry·2025
Same author

Thyroid-Stimulating Hormone Testing and Outcomes in Total Laryngectomy Patients.

The Annals of otology, rhinology, and laryngology·2025
Same author

A new psychotherapy that may treat PTSD in one session.

Frontiers in psychiatry·2024
Same author

How Should Therapists Treat Patients who are so Altruistic They Regularly Harm Themselves for the Sake of Others?

Innovations in clinical neuroscience·2024
Same author

Psychotherapeutic approaches: hopefully, globally effective.

Frontiers in psychiatry·2024
Same author

Addressing Structural Audism in Medicine: How Those Who are Deaf and Hard of Hearing are Marginalized in Healthcare.

Psychiatry·2024

Related Experiment Video

Updated: Jun 12, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Alzheimer's therapies.

Elisa F Cascade1, Amir H Kalali, Edmund Howe

  • 1Ms. Cascade is Vice President, Strategic Research and Safety, Quintiles Inc., Falls Church, Virginia.

Psychiatry (Edgmont (Pa. : Township))
|June 10, 2010
PubMed
Summary
This summary is machine-generated.

Psychiatrists prescribe Alzheimer's disease therapies, often alongside antipsychotics and antidepressants, differing from neurologists and primary care physicians. This study highlights unique prescribing patterns in psychiatric care for neurodegenerative conditions.

Keywords:
Alzheimer's diseaseantidepressantsantiepilepticsantipsychoticsdementianeurologyprimary care

Related Experiment Videos

Last Updated: Jun 12, 2026

Transcranial Pulse Stimulation for Alzheimer's Patients
06:08

Transcranial Pulse Stimulation for Alzheimer's Patients

Published on: April 4, 2025

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Alzheimer's disease (AD) treatment involves multiple specialists.
  • Understanding prescriber patterns is crucial for optimizing AD therapy.
  • Psychiatrists' role in AD pharmacotherapy is not fully elucidated.

Purpose of the Study:

  • To investigate the role of psychiatrists in prescribing Alzheimer's disease therapies.
  • To compare treatment approaches of psychiatrists with primary care physicians (PCPs) and neurologists.
  • To identify differences in concomitant medication use.

Main Methods:

  • Retrospective analysis of prescription data for Alzheimer's disease therapies.
  • Comparison of prescribing patterns across psychiatrists, PCPs, and neurologists.
  • Analysis of specific diagnoses and co-prescribed medication classes.

Main Results:

  • Psychiatrists account for 7.6% of new Alzheimer's disease therapy starts.
  • Commonly prescribed diagnoses by psychiatrists include Other Organic Psychiatric Condition and Cerebral Degeneration.
  • Psychiatrists significantly more often co-prescribe antipsychotics (27%), antidepressants (12%), and antiepileptics (9%) compared to PCPs and neurologists (<5%).

Conclusions:

  • Psychiatrists exhibit distinct concomitant prescribing patterns for Alzheimer's disease therapies.
  • The frequent use of antipsychotics, antidepressants, and antiepileptics by psychiatrists warrants further investigation.
  • Understanding these differences may inform collaborative care models for Alzheimer's disease management.